TP53 and cancer: Nevertheless, TP53 gene mutations in cancer cells are expected to compromise or ablate these effects of wild-type p53 on TSAP6-dependent exosome production, and TSAP6 expression alone is sufficient to restore DNA damage-inducible exosome secretion to p53-null cells [79].